This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...
Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.
Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.
Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...
Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price ...
Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...
The study aims to assess the Catheter and Affera system in patients who have ventricular tachycardia (VT) due to scarring ...
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...